Lactose modifications enhance its drug performance in the novel multiple dose Taifun ( R) DPI

Author： Harjunen P. Lehto V.-P. Martimo K. Suihko E. Lankinen T. Paronen P. Jarvinen K.

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.16, Iss.4, 2002-09, pp. : 313-321

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Influence of Lactose Pseudopolymorphic Form on Salbutamol Sulfate-Lactose Interactions in DPI Formulations

By Traini Daniela Young Paul Thielmann Frank Acharya Manaswini

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 9, 2008-09 ,pp. : 992-1001

Informa Healthcare

Access to resources Recommend Favorite

Multiple-dose pharmacokinetics confirm no accumulation and dose proportionality of the novel promotile drug tegaserod (HTF 919)

By Appel-Dingemanse S. Hirschberg Y. Osborne S. Pommier F. McLeod J.

European Journal of Clinical Pharmacology, Vol. 56, Iss. 12, 2001-03 ,pp. : 889-891

Springer Publishing Company

Access to resources Recommend Favorite

Methods for reduction of cohesive forces between carrier and drug in DPI formulation

By Desai Swapnil S. Aher Abhijeet A. Kadaskar Preeti T.

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 11, 2013-11 ,pp. : 1589-1598

Informa Healthcare

Access to resources Recommend Favorite

Dose and Frequency of Administration of Interferon- Affect its Efficacy in Multiple Sclerosis

By Sharief M.K.

Clinical Drug Investigation, Vol. 23, Iss. 9, 2003-01 ,pp. : 551-559

Adis International

Access to resources Recommend Favorite

Using multiple coders to enhance qualitative analysis: The case of interviews with consumers of drug treatment

By Berends Lynda Johnston Jennifer

Addiction Research and Theory, Vol. 13, Iss. 4, 2005-08 ,pp. : 373-381

Informa Healthcare

Access to resources Recommend Favorite